EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis

Li Z Luo, Jung-Hyun Kim, Iliana Herrera, Shaoguang Wu, Xinqun Wu, Seong-Sik Park, Juyoung Cho, Leslie Cope, Lingling Xian, Bailey E West, Julian Calderon-Espinosa, Joseph Kim und 8 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci184442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Li Z Luo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Basic Helix-Loop-Helix Proteins, Epigenesis, Genetic, Colonic Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutated tumor cells undergo changes in chromatin accessibility and gene expression, resulting in aberrant proliferation and differentiation, although how this occurs is unclear. HMGA1 chromatin regulators are abundant in stem cells and oncogenic in diverse tissues; however, their role in colon tumorigenesis is only beginning to emerge. Here, we uncover a previously unknown epigenetic program whereby HMGA1 amplifies Wnt signaling during colon tumorigenesis driven by inflammatory microbiota and/or Adenomatous polyposis coli ( Apc ) inactivation. Mechanistically, HMGA1 “opens” chromatin to upregulate the stem cell regulator, Ascl2, and downstream Wnt effectors, promoting stem and Paneth-like cell states while depleting differentiated enterocytes. Loss of just one Hmga1 allele within colon epithelium restrains tumorigenesis and Wnt signaling driven by mutant Apc and inflammatory microbiota. However, HMGA1 deficiency has minimal effects in colon epithelium under homeostatic conditions. In human colon cancer cells, HMGA1 directly induces ASCL2 by recruiting activating histone marks. Silencing HMGA1 disrupts oncogenic properties, whereas reexpression of ASCL2 partially rescues these phenotypes. Further, HMGA1 and ASCL2 are coexpressed and upregulated in human colorectal cancer. Together, our results establish HMGA1 as an epigenetic gatekeeper of Wnt signals and cell state under conditions of APC inactivation , illuminating HMGA1 as a potential therapeutic target in colon cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wnt Signaling PathwayBasic Helix-Loop-Helix ProteinsEpigenesis, GeneticColonic NeoplasmsHMGA1a ProteinCarcinogenesisNeoplasm ProteinsHumansAnimalsMiceAdenomatous Polyposis Coli ProteinGene Expression Regulation, NeoplasticMice, Knockout

Stichwörter der Autor:innen

Colorectal cancerEpigeneticsOncologyTranscription

Substanzen

Basic Helix-Loop-Helix ProteinsHMGA1a ProteinAdenomatous Polyposis Coli ProteinNeoplasm ProteinsASCL2 protein, humanAscl2 protein, mouse

Autor:innen und Institutionen

  • Division of Hematology, Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Research Institute, National Cancer Center, Goyang-si, Gyeonggido, Republic of Korea.
  • Division of Infectious Diseases, Department of Medicine.
  • Sidney Kimmel Comprehensive Cancer Center, Division of Biostatistics.
  • Pathobiology Graduate Program, Department of Pathology, and.
  • Human Genetics Graduate Program, Department of Genetics and Molecular Medicine, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • Maryland Stem Cell Research Fund
  • National Cancer Center

Zitieren

APA

Luo, L. Z., Kim, J. H., Herrera, I., Wu, S., Wu, X., Park, S. S., Cho, J., Cope, L., Xian, L., West, B. E., Calderon-Espinosa, J., Kim, J., Thompson, Z., Maloo, I., Larman, T., Reddy, K. L., Feng, Y., Fearon, E. R., Sears, C. L., & Resar, L. (2025). HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis. Journal of Clinical Investigation. https://doi.org/10.1172/jci184442

Vancouver

Luo LZ, Kim JH, Herrera I, Wu S, Wu X, Park SS, et al. HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis. Journal of Clinical Investigation. 2025. doi:10.1172/jci184442

BibTeX
@article{Luo2025,
  author = {Luo, Li Z and Kim, Jung-Hyun and Herrera, Iliana and Wu, Shaoguang and Wu, Xinqun and Park, Seong-Sik and Cho, Juyoung and Cope, Leslie and Xian, Lingling and West, Bailey E and Calderon-Espinosa, Julian and Kim, Joseph and Thompson, Zanshé and Maloo, Isha and Larman, Tatianna and Reddy, Karen L and Feng, Ying and Fearon, Eric R and Sears, Cynthia L and Resar, Linda},
  title = {HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci184442}
}
Kostenlos starten →